In order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4'-dimethoxy-2-2'-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO4)2], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO4)2] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with Kb values in the range of 103-104 M-1, with [Cu(4-MH)(dmb)(ClO4)2] showing the highest Kb value (1.45 × 104 M-1). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO4)2] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond.
Arboviral diseases such as Zika, Mayaro and chikungunya fevers are neglected infections transmitted by arthropod vectors. The search for alternatives to circumvent the effects of arboviruses by modifying molecules previously known for their antiviral activities can be considered a good strategy to obtain new antiviral drugs. Here, we describe the synthesis of novel adamantane‑derived Schiff bases and their antiviral activities against Zika (ZIKV), Mayaro (MAYV) and chikungunya (CHIKV) viruses. Amantadine Schiff base was prepared by reaction of amantadine and 2-thiophenecarboxyaldehyde (atdTiof), while rimantadine Schiff base was prepared by reaction of rimantadine and 5-fluoro-2-hydroxybenzaldehyde (rtdFhba). The compositions of the Schiff bases were determined by elemental and mass spectrometric analyses as C15H19NS and C19H24FNO for atdTiof and rtdFhba, respectively. Spectroscopic characterizations added to single crystal X-ray diffraction permitted proposing the structures of Schiff bases. Cell viability and antiviral activities of the compounds were evaluated against ZIKV, MAYV and CHIKV viruses. The atdTiof and rtdFhba species exhibited the best inhibition rates of 58.5% over ZIKV and 69.5% over CHIKV, respectively. The results obtained in the in vitro studies open perspectives for future in vivo investigations of the synthesized Schiff bases in the search for alternatives for the treatment of arboviruses.